KAYTUS
14.5.2024 09:01:37 CEST | Business Wire | Press release
KAYTUS, a leading IT infrastructure provider, has unveiled its latest upgrade, the K24V2 multi-node server, at ISC High Performance 2024. This server supports four dual-socket nodes within a compact 2U form factor, featuring a total of eight cutting-edge Intel/AMD processors. The K24V2 incorporates advanced cooling technologies optimized for extreme computing density, offering both cold plate liquid cooling and air cooling configurations. Notably, the liquid-cooling K24V2 cools components that account for more than 80% of the total power consumption, while the air-cooled variant supports CPU cooling with a TDP of up to 400W. With its emphasis on high performance, energy efficiency, and exceptional reliability, the K24V2 is tailored for demanding tasks such as modeling, simulation, and other performance-intensive applications.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240513994533/en/
K24V2 Multi-Node Server (Photo: Business Wire)
Achieving Four Times Computing Density and Higher Performance
The K24V2 server enables support for four dual-socket nodes within a 2U form factor, allowing for independent operations between nodes. Each node is compatible with two 5th Gen Intel® Xeon® processors or the latest 4th Gen AMD EPYC™ processors. It supports memory configurations up to 5600MT/s, and each node can accommodate various networking extensions such as InfiniBand, Omni-Path Architecture, and RoCE, meeting the networking requirements for HPC clusters.
Leading Cooling Solutions for Enhanced Performance and Efficiency
The liquid-cooled configuration of the K24V2 incorporates an integrated cold plate design that covers key components including the CPU, memory, and VR (Voltage Regulator). Components accounting for more than 80% of total power consumption are liquid cooled, offering efficient cooling while balancing investment control and power usage for heat dissipation. The cold plate supports various liquid-cooling connectors like SCG 03 and DAG 03, ensuring compatibility with different liquid-cooling cabinets used in data centers. The K24V2 is capable of supporting high-temperature inlet cooling liquids of up to 45°C, with the primary loop capable of drawing intake from a natural draft cooling tower. Furthermore, engineered to operate efficiently at an industry-leading ambient temperature of 45°C, this system significantly reduces energy consumption in data center operations.
The air-cooled version of the K24V2 maximizes heat dissipation performance through a high air intake design and a customized heat sink. This variant supports high-density deployments with CPUs of up to 400W TDP, delivering ultra-high performance and dense computing power tailored for air-cooled data centers.
Ensuring Security and Reliability, Streamlining Operations and Maintenance
Aside from delivering industry-leading performance per watt, the K24V2 is highly secure and reliable. The four nodes share titanium power supply units (PSUs), and the entire system supports N+N or 3+1 redundancy configurations. The liquid-cooled version features an integrated cold plate design and undergoes rigorous inspection processes before leaving the factory, including a nitrogen pressure test to effectively prevent leaks. Notably, the liquid-cooled version can identify leaking nodes in real-time, automatically cutting off node power to ensure the safety of equipment and data assets.
The K24V2 enhances user experience by offering convenient operation and maintenance features. The four nodes support hot-swappable maintenance and feature a "button"-style node switching on the front panel. This simplifies the connection of maintenance equipment for unified operations and maintenance, reduces work in the backend hot air duct, and improves overall user-friendliness.
To learn more about the new KAYTUS K24V2 Multi-Node Server, please visit our website.
About KAYTUS
KAYTUS is a prominent provider of IT infrastructure solutions, delivering a diverse range of innovative, open, and eco-friendly products for cloud, AI, edge computing, and other emerging applications. With a customer-centric approach, KAYTUS is agile and responsive to user needs through its adaptable business model. Discover more at KAYTUS.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240513994533/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom